Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Risk Assessment
Disparities in phase 1 cancer clinical trial enrollment.
Neurons, Afferent
Pelger-Huet Anomaly
Cutaneous adverse effects of the immune checkpoint inhibitors.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cutaneous adverse effects of the immune checkpoint inhibitors.
Cutaneous adverse effects of the immune checkpoint inhibitors. Curr Probl Cancer. 2017 Mar - Apr; 41(2):125-128.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antineoplastic Agents
Humans
Immunomodulation
Neoplasms
Skin Diseases
authors with profiles
Lindsey K Collins